Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 102

Published Date: 14 Jan 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Increasing geriatric population across the globe coupled with increasing demand for cardiovascular, orthopaedic, digestive, and other surgical procedures is expected to fuel consumption of surgical hemostats, internal tissue sealants and adhesion barriers market.

According to our (Global Info Research) latest study, the global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market size was valued at USD 4387.4 million in 2022 and is forecast to a readjusted size of USD 6951.1 million by 2029 with a CAGR of 6.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Primary factors fuelling demand for surgical hemostats, internal tissue sealants and adhesion barriers are rapidly ageing population with rising cardiovascular, digestive, orthopaedic and other surgical procedures, strong healthcare consciousness and availability of new surgical adhesives for various surgical application.

This report is a detailed and comprehensive analysis for global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market size and forecasts, in consumption value ($ Million), 2018-2029
Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter, Ethicon, B. Braun Melsungen, Sanofi and C. R. Bard, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Hemostats
    Internal Tissue Sealants
    Adhesion Barriers

Market segment by Application
    Hospitals
    Clinics & Trauma Centers
    Ambulatory Surgical Centers

Market segment by players, this report covers
    Baxter
    Ethicon
    B. Braun Melsungen
    Sanofi
    C. R. Bard
    Integra Lifesciences
    Cryolife
    Tissuemed
    Cohera Medical
    Pfizer

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers, with revenue, gross margin and global market share of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers from 2018 to 2023.
Chapter 3, the Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers.
Chapter 13, to describe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers by Type
        1.3.1 Overview: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Market Share by Type in 2022
        1.3.3 Hemostats
        1.3.4 Internal Tissue Sealants
        1.3.5 Adhesion Barriers
    1.4 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market by Application
        1.4.1 Overview: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospitals
        1.4.3 Clinics & Trauma Centers
        1.4.4 Ambulatory Surgical Centers
    1.5 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size & Forecast
    1.6 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Forecast by Region
        1.6.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region, (2018-2029)
        1.6.3 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Prospect (2018-2029)
        1.6.4 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Prospect (2018-2029)
        1.6.6 South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Baxter
        2.1.1 Baxter Details
        2.1.2 Baxter Major Business
        2.1.3 Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
        2.1.4 Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Baxter Recent Developments and Future Plans
    2.2 Ethicon
        2.2.1 Ethicon Details
        2.2.2 Ethicon Major Business
        2.2.3 Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
        2.2.4 Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Ethicon Recent Developments and Future Plans
    2.3 B. Braun Melsungen
        2.3.1 B. Braun Melsungen Details
        2.3.2 B. Braun Melsungen Major Business
        2.3.3 B. Braun Melsungen Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
        2.3.4 B. Braun Melsungen Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 B. Braun Melsungen Recent Developments and Future Plans
    2.4 Sanofi
        2.4.1 Sanofi Details
        2.4.2 Sanofi Major Business
        2.4.3 Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
        2.4.4 Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Sanofi Recent Developments and Future Plans
    2.5 C. R. Bard
        2.5.1 C. R. Bard Details
        2.5.2 C. R. Bard Major Business
        2.5.3 C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
        2.5.4 C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 C. R. Bard Recent Developments and Future Plans
    2.6 Integra Lifesciences
        2.6.1 Integra Lifesciences Details
        2.6.2 Integra Lifesciences Major Business
        2.6.3 Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
        2.6.4 Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Integra Lifesciences Recent Developments and Future Plans
    2.7 Cryolife
        2.7.1 Cryolife Details
        2.7.2 Cryolife Major Business
        2.7.3 Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
        2.7.4 Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Cryolife Recent Developments and Future Plans
    2.8 Tissuemed
        2.8.1 Tissuemed Details
        2.8.2 Tissuemed Major Business
        2.8.3 Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
        2.8.4 Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Tissuemed Recent Developments and Future Plans
    2.9 Cohera Medical
        2.9.1 Cohera Medical Details
        2.9.2 Cohera Medical Major Business
        2.9.3 Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
        2.9.4 Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Cohera Medical Recent Developments and Future Plans
    2.10 Pfizer
        2.10.1 Pfizer Details
        2.10.2 Pfizer Major Business
        2.10.3 Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
        2.10.4 Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Pfizer Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers by Company Revenue
        3.2.2 Top 3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Players Market Share in 2022
        3.2.3 Top 6 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Players Market Share in 2022
    3.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market: Overall Company Footprint Analysis
        3.3.1 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market: Region Footprint
        3.3.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market: Company Product Type Footprint
        3.3.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Market Share by Application (2018-2023)
    5.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Type (2018-2029)
    6.2 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Application (2018-2029)
    6.3 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country
        6.3.1 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Country (2018-2029)
        6.3.2 United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Forecast (2018-2029)
        6.3.3 Canada Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Forecast (2018-2029)
        6.3.4 Mexico Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Type (2018-2029)
    7.2 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Application (2018-2029)
    7.3 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country
        7.3.1 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Country (2018-2029)
        7.3.2 Germany Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Forecast (2018-2029)
        7.3.3 France Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Forecast (2018-2029)
        7.3.5 Russia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Forecast (2018-2029)
        7.3.6 Italy Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region
        8.3.1 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Region (2018-2029)
        8.3.2 China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Forecast (2018-2029)
        8.3.3 Japan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Forecast (2018-2029)
        8.3.4 South Korea Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Forecast (2018-2029)
        8.3.5 India Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Forecast (2018-2029)
        8.3.7 Australia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Type (2018-2029)
    9.2 South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Application (2018-2029)
    9.3 South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country
        9.3.1 South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Country (2018-2029)
        9.3.2 Brazil Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Forecast (2018-2029)
        9.3.3 Argentina Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country
        10.3.1 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Country (2018-2029)
        10.3.2 Turkey Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Forecast (2018-2029)
        10.3.4 UAE Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Drivers
    11.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Restraints
    11.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Industry Chain
    12.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Upstream Analysis
    12.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Midstream Analysis
    12.4 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Baxter Company Information, Head Office, and Major Competitors
    Table 6. Baxter Major Business
    Table 7. Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
    Table 8. Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Baxter Recent Developments and Future Plans
    Table 10. Ethicon Company Information, Head Office, and Major Competitors
    Table 11. Ethicon Major Business
    Table 12. Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
    Table 13. Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Ethicon Recent Developments and Future Plans
    Table 15. B. Braun Melsungen Company Information, Head Office, and Major Competitors
    Table 16. B. Braun Melsungen Major Business
    Table 17. B. Braun Melsungen Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
    Table 18. B. Braun Melsungen Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. B. Braun Melsungen Recent Developments and Future Plans
    Table 20. Sanofi Company Information, Head Office, and Major Competitors
    Table 21. Sanofi Major Business
    Table 22. Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
    Table 23. Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Sanofi Recent Developments and Future Plans
    Table 25. C. R. Bard Company Information, Head Office, and Major Competitors
    Table 26. C. R. Bard Major Business
    Table 27. C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
    Table 28. C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. C. R. Bard Recent Developments and Future Plans
    Table 30. Integra Lifesciences Company Information, Head Office, and Major Competitors
    Table 31. Integra Lifesciences Major Business
    Table 32. Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
    Table 33. Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Integra Lifesciences Recent Developments and Future Plans
    Table 35. Cryolife Company Information, Head Office, and Major Competitors
    Table 36. Cryolife Major Business
    Table 37. Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
    Table 38. Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Cryolife Recent Developments and Future Plans
    Table 40. Tissuemed Company Information, Head Office, and Major Competitors
    Table 41. Tissuemed Major Business
    Table 42. Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
    Table 43. Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Tissuemed Recent Developments and Future Plans
    Table 45. Cohera Medical Company Information, Head Office, and Major Competitors
    Table 46. Cohera Medical Major Business
    Table 47. Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
    Table 48. Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Cohera Medical Recent Developments and Future Plans
    Table 50. Pfizer Company Information, Head Office, and Major Competitors
    Table 51. Pfizer Major Business
    Table 52. Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
    Table 53. Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Pfizer Recent Developments and Future Plans
    Table 55. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million) by Players (2018-2023)
    Table 56. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Share by Players (2018-2023)
    Table 57. Breakdown of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 58. Market Position of Players in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 59. Head Office of Key Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Players
    Table 60. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market: Company Product Type Footprint
    Table 61. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market: Company Product Application Footprint
    Table 62. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers New Market Entrants and Barriers to Market Entry
    Table 63. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Mergers, Acquisition, Agreements, and Collaborations
    Table 64. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (USD Million) by Type (2018-2023)
    Table 65. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Share by Type (2018-2023)
    Table 66. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Forecast by Type (2024-2029)
    Table 67. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Application (2018-2023)
    Table 68. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Forecast by Application (2024-2029)
    Table 69. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Type (2018-2023) & (USD Million)
    Table 70. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Type (2024-2029) & (USD Million)
    Table 71. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Application (2018-2023) & (USD Million)
    Table 72. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Application (2024-2029) & (USD Million)
    Table 73. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Country (2018-2023) & (USD Million)
    Table 74. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Country (2024-2029) & (USD Million)
    Table 75. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Type (2018-2023) & (USD Million)
    Table 76. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Type (2024-2029) & (USD Million)
    Table 77. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Application (2018-2023) & (USD Million)
    Table 78. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Application (2024-2029) & (USD Million)
    Table 79. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Country (2018-2023) & (USD Million)
    Table 80. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Country (2024-2029) & (USD Million)
    Table 81. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Type (2018-2023) & (USD Million)
    Table 82. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Type (2024-2029) & (USD Million)
    Table 83. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Application (2018-2023) & (USD Million)
    Table 84. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Application (2024-2029) & (USD Million)
    Table 85. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Region (2018-2023) & (USD Million)
    Table 86. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Region (2024-2029) & (USD Million)
    Table 87. South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Type (2018-2023) & (USD Million)
    Table 88. South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Type (2024-2029) & (USD Million)
    Table 89. South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Application (2018-2023) & (USD Million)
    Table 90. South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Application (2024-2029) & (USD Million)
    Table 91. South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Country (2018-2023) & (USD Million)
    Table 92. South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Country (2024-2029) & (USD Million)
    Table 93. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Type (2018-2023) & (USD Million)
    Table 94. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Type (2024-2029) & (USD Million)
    Table 95. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Application (2018-2023) & (USD Million)
    Table 96. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Application (2024-2029) & (USD Million)
    Table 97. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Country (2018-2023) & (USD Million)
    Table 98. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Country (2024-2029) & (USD Million)
    Table 99. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Raw Material
    Table 100. Key Suppliers of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Raw Materials
List of Figures
    Figure 1. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Picture
    Figure 2. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Market Share by Type in 2022
    Figure 4. Hemostats
    Figure 5. Internal Tissue Sealants
    Figure 6. Adhesion Barriers
    Figure 7. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 8. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Market Share by Application in 2022
    Figure 9. Hospitals Picture
    Figure 10. Clinics & Trauma Centers Picture
    Figure 11. Ambulatory Surgical Centers Picture
    Figure 12. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Market Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 15. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Market Share by Region (2018-2029)
    Figure 16. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Market Share by Region in 2022
    Figure 17. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 18. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 19. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 20. South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 21. Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 22. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Share by Players in 2022
    Figure 23. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 24. Global Top 3 Players Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share in 2022
    Figure 25. Global Top 6 Players Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share in 2022
    Figure 26. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Share by Type (2018-2023)
    Figure 27. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share Forecast by Type (2024-2029)
    Figure 28. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Share by Application (2018-2023)
    Figure 29. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share Forecast by Application (2024-2029)
    Figure 30. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Market Share by Type (2018-2029)
    Figure 31. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Market Share by Application (2018-2029)
    Figure 32. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Market Share by Country (2018-2029)
    Figure 33. United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 34. Canada Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 35. Mexico Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 36. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Market Share by Type (2018-2029)
    Figure 37. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Market Share by Application (2018-2029)
    Figure 38. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Market Share by Country (2018-2029)
    Figure 39. Germany Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 40. France Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 41. United Kingdom Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 42. Russia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 43. Italy Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 44. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Market Share by Type (2018-2029)
    Figure 45. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Market Share by Application (2018-2029)
    Figure 46. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Market Share by Region (2018-2029)
    Figure 47. China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 48. Japan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 49. South Korea Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 50. India Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 51. Southeast Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 52. Australia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 53. South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Market Share by Type (2018-2029)
    Figure 54. South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Market Share by Application (2018-2029)
    Figure 55. South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Market Share by Country (2018-2029)
    Figure 56. Brazil Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 57. Argentina Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 58. Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Market Share by Type (2018-2029)
    Figure 59. Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Market Share by Application (2018-2029)
    Figure 60. Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value Market Share by Country (2018-2029)
    Figure 61. Turkey Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 62. Saudi Arabia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 63. UAE Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Value (2018-2029) & (USD Million)
    Figure 64. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Drivers
    Figure 65. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Restraints
    Figure 66. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers in 2022
    Figure 69. Manufacturing Process Analysis of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
    Figure 70. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Baxter
Ethicon
B. Braun Melsungen
Sanofi
C. R. Bard
Integra Lifesciences
Cryolife
Tissuemed
Cohera Medical
Pfizer

Related Reports

Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 01 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market size was valued at USD 4387.4 million in 2023 and is forecast to a readjusted size of USD 6951.1 million by 2030 with a CAGR of 6.8% during review period.

Product Tags

Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>